2d
Zacks.com on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, ...
A first-of-its-kind online course, 'Genomics Our Way - An Introduction to Genomics Research with Indigenous Australians', has ...
Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...
Nucleus Genomics claims to give couples a picture of their combined risk for passing down hundreds of conditions to their ...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...
Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free ...
Bionano Genomics (BNGO) and Greenwood Genetic Center announced a publication in Genome Research describing the first study to use optical ...
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics presented results showing a refined approach to detect drug-induced testicular toxicity using Singlera’s cell-free DNA methylation ...
Circular Genomics, originally founded in New Mexico, and who specializes in circular RNA (circRNA) biomarkers for precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results